Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with ...
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...
Posters feature innovative technologies that address limitations of gene therapy production LAUSANNE, SWITZERLAND, October 17, 2024 ...
The14th Binniel Lake Conference held here in the campus town of Moodabidire ended on Sunday with a call to sensitise GenX ...
Detailed price information for Nkgen Biotech Inc (NKGN-Q) from The Globe and Mail including charting and trades.
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that five abstracts have been accepted for e-Poster ...
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...
Poster presentations include data supporting QTORIN™ rapamycin 3.9% anhydrous gel as a potential targeted therapy for the ...
Additional information on ASN Kidney Week 2024 can be accessed online at: https://www.asn-online.org/education/kidneyweek ...
SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback